The shares of BioLife Solutions (BLFS) have crashed with the market:
Since we are long in the shares of Biolife Solutions, it's worthwhile to start with our simple investment thesis which consists of the following elements:
- The market for gene and cell therapies is in the early innings
- The company is taking market share, raking in new customers
- As existing customers go through different regulatory phases, demand will automatically increase
- A big jump in customer revenue occurs when their therapy gets approval and goes from pre-commercial trials into commercial production
- The company is